MUCZ and MUC3 are prominent mucin genes expressed in the human intestine. Using in situ hybridization with RNA probes, we examined the cellular distribution of MUC2 and MUC3 mRNA in normal, malignant, and inflamma tory human intestinal tissues. In normal small intestine and colon, MUCZ mRNA was expressed exclusively in goblet cells and occurred throughout the entice height of the mucosa. MUC3 mRNA was expressed by goblet and columnar cells but was restricted to the villous com tment of the s m a l l intestine and MUC3 mRNA were both markedly decreased in poorly, moderately, and well-di&rentiated colon cancers but were preserved in mucinous colon cancers. In ulcerative colitis and Crohn's colitis tissues, MUC2 and MUC3 "A expression and the surface epithelium o r the colon. Expression of MUCZ
Introduction
Alterations of mucin are a well-documented feature of both colorectal cancer and inflammatory bowel disease. Many studies have described alterations in the expression of carbohydrate antigens in these disease states (Itzkowitz et al., 1995; Itzkowitz, 1992; Neutra and Forstner, 1987; Filipe, 1979) , but because a number of carbohydrate antigens can occur on both mucin-type glycoproteins and glycolipids, immunohistochemistry with lectins or monoclonal antibodies (MAbs) directed against carbohydrate determinants may not accurately reflect the expression of the underlying mucin.
Immunohistochemistry with antibodies directed against apomucin peptides has revealed that in normal human colon, MUC2, MUC3, and MUC5B are frequently expressed, but there has been controversy as to whether or not MUCl is expressed (Carrato et al., 1994; Lesuffleur et al., 1994; Nakomori et al., 1994; Tytgat et al., 1994; Andrews et al., 1993; Ho et al., 1993; Byrd et al., 1991; Girling displayed a normal pattern regardless of whether the mucosa manifested active or quiescent inflammation. These findings indicate that MUCZ is goblet cell-specific, whereas MUC3 is related to maturation of intestinal epithelial cells. In colon cancers, the genetic regulation of MUC2 and MUC3 is difikent depending on the histological type of tumor. The constitutive expression of MUCZ and MUC3 mRNA in inflammatory bowel diseases suggests that these genes may be necessary for maintenance of normal epithelial cell function during inflammation. ( J fi'stochem Cytochem 44: Zotter et al., 1988) . In colon cancer, MUCl apomucin is frequently expressed, whereas MUCZ and MUC3 apomucins are often decreased compared to normal mucosa (Carrato et al., 1994; Chang et al., 1994; Lesuffleur et al., 1994; Nakomori et al., 1994) .
A problem with immunohistochemical studies using antiapomucin antibodies is that the peptide epitopes they recognize could be glycosylated, preventing these antibodies from binding to their epitope and thereby giving a falsely negative impression of mucin gene expression. For example, we have observed that the anti-MUC1 antibody SM3 reacts very weakly if at all with normal colon mucosa, but if the same tissue is treated with sodium periodate to alter the carbohydrate side chains, expression of MUCl apomucin is revealed (unpublished obervations). Now that the cDNAs for several human mucin genes have been cloned (Gendler and Spicer, 1995) , knowledge of specific mucin expression in different tissues is increasing. To more accurately determine mucin gene expression in the colon, we previously performed Northern blot hybridization with probes detecting MUC1-MUC4 "As in normal and malignant human colon tissues (Ogata et al., 1992) . This investigation revealed that MUCl mRNA was indeed expressed in normal colon, as were the other three mucin genes. In colon cancer, MUCl and MUC4 mRNA levels were not altered significantly from normal levels, whereas MUC2 and MUC3 mRNA levels were usually decreased. 1161 Although Northern blot hybridization is a helpful means of elucidating gene expression, it does not provide insight into the cellular distribution of mucin gene expression. In the present investigation, MUCZ and MUC3 gene expression was studied by in situ hybridization to gain a better understanding of mucin gene expression at the cellular level. In addition, because no studv has yet examined the cellular distribution of mucin gene expression in inflammatory bowel disease, we were curious to study the effect of inflammation on the expression of mucin genes.
Materials and Methods
Preparation of Tissues. Surgical specimens from patients with Crohn's disease (ileitis, n = 2: ileocolitis. n = 2; colitis. n = 3), ulcerative colitis (n = 8). and colorectal cancer (n = 6) were obtained directly from the operating room and placed directly in neutral buffered formaldehyde for a minimum of 24 hr. Histologically normal margins remote from colon cancer served as a control. as did one resection specimen from a patient with colon diverticular disease. Normal small intestinal tissue was obtained from a patient who underwent a resection for benign small intestinal obstruction.
Preparation of Slides. Tissue specimens were embedded in paraffin and sections were cut at a thickness of 5 pm and floated in 0.1% DEPC-treated water (diethylpyrocarbonate) (Sigma Chemical; St Louis, MO). The floated sections were collected on Superfrost slides (Fisher Scientific: Fair Lawn, NJ) and allowed to dry overnight at 37'C.
In preparation for in situ hybridization, sections were deparaffinized in xylene twice for 8 min each and rehydrated through 100. 80, 60, and 30% ethanol and Dulbecco's phosphate buffered saline (PBS. pH 7.4)containing 0.1% DEPC. Sections were then incubated with proteinase K (20 pglml in TE buffer consisting of 50 mM Tris-HCI and 5 mM EDTA, pH 8.0) at 37°C for 10 min and were rinsed twice in PBS containing 0.2% glycine and then in PBS alone for 5 min each. Specimens were then fixed in freshly prepared 4% paraformaldehyde in PBS for 20 min at room temperature and rinsed again thrcc times in PBS. The tissuawerc then acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine. rinsed again in PBS. and dehydrated through graded alcohols containing 0.1% DEPC.
._ -RNA Probes. The cDNAs for MUCZ (SMUC 41) (Gum et al.. 1989) and MUC3 (SIB 124) (Gum et al., 1990) cloned in pBluexript SK were obtained from Dr. Sandra Gendlcr (Imperial Cancer Research Fund, London, UK). The plasmids were linearized with Hind 111 (sense) and Pst I (anti-sense) at 37'C for 1 hr and extracted with phenol-chloroform (1:1 vlv). The DNA was precipitated with 2.5 x volume ethanol and 0.3 M sodium acetate (pH 5.2) in dry ice for 2 hr. The precipitateswcre then washed with 70% ethanol and dissolved in DEPC water to a concentration of 1 pglml. Completion of digestion was confirmed by agarose gel electropho-
resis.
3'S-labeled sense and anti-sense RNA probes were prepared using T3 and T7 polymerases. respectively. Transcription reactions were performed at 37°C for 60 min and the templates were subsequently destroyed by add- 3 (B,D) mRNA. MUCP is expressed in a punctate fashion in goblet cells throughout the crypt-villous column of small intestine and the entire crypt height of the colon (arrows). M U C 3 is expressed by both goblet and columnar cells, but the expression is restricted to thevillous compartment in the small intestine and the surface epithelium in the colon. Bars = 50 wm. I p-
. .
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ing 1 pI of DNAse (RNAse free, 1 pllml) at 37°C for 15 min. The RNA probes were then purified by centrifugation in a Chromaspin-30 column (Clontech Labs; Palo Alto, CA). Radioactivity was measured in a xintillation counter to confirm a minimum of 40% incorporation of 31S.
Hybridization Procedure. Hybridization bufferlprobc was prepared according to the following specifications: 10 x salts solution (3 M NaCI. 100 mM NazHP04.100 mM Tris-HCI. 50 mM EDTA) (10%). formamide (50%), rRNA (10 mglml; 3%), dextran sulfate (500 mglml; preheated to 80'C; 20%). and 1 M dithiothreitol (1%). The final volume was made up with DEPC-treated water and sufficient probe to place 1 x 1 0 ' cpm in 25 pl per slide. The buffer/probc solution was then heated at 80'C for 1 min and pipetted onto each slide. Slides were coverslipped and then placed in a humidified chamber containing 0.4-mm blot paper saturated with excess hybridization buffer. The humidified chamber was then placed in an incubator maintained at 55'C overnight.
After hybridization, slides were washed with a 50% formamide buffer at 55'C for 4 hr and then at 37% in TNE buffer (146 g NaCI. 50 ml 1 M Tris-HCI pH 7.6, 25 mlO.2 M EDTA. pH 7.5, diluted to 5 liten in deionized --. H20) for45 min in a shaking water bath. Slides were then incubated in 100 pglml RNAse A in TNE buffer at 37'C for 1 hr, followed by 30 min in 2 x sodium chloride-sodium citrate (SSC) (Sambrook, 1989) at 65°C and 30 min in 0.5 x SSC at 65°C. The slides were subsequently dehydrated and placed through graded alcohols from 30 to 100% containing 0.3 M ammonium acetate.
After drying, slides were dipped in photographic emulsion (Kodak "2) heated to 40'C and dried for 2.5 hr. After keeping slides in the dark at 4'C for 13 days, they were developed (Kodak D-19 developer) and stained with hematoxylin and eosin.
Results

Normal IntestinuZ Tissue
The expressions of MUCZ and MUC3 mRNA were quite distinct from each other in the small intestine and in the colon. In the small intestine, MUC2 mRNA was expressed by goblet cells in a punctate, apparently perinuclear fashion. The expression was equally strong in both crypts and villi of the small intestine ( Figure IA) . In contrast, MUC3 mRNA was expressed by both goblet and columnar cells (Figure 1B) . There was a striking maturational pattern for MUC3 whereby expression was restricted to the villous compartment without any expression in the crypts of Lieberkuhn.
In the colon, the distribution of each mucin gene was similar to the pattern observed in the small intestine. MUC2 mRNA was expressed by goblet cells throughout the colonic crypt (Figure IC) . MUC3 mRNA was expressed by both goblet and columnar cells, but such expression was confined to the surface epithelium (Figure 1D) .
Colorectal Cancer
In colorectal cancer, expression of both mucin genes was decreased. Curiously, however, this decrease was observed only in areas of well-, moderately. or poorly differentiated carcinoma, whereas areas of colloid carcinoma demonstrated preservation of MUC2 and MUC3 mRNA expression (Figures 2A and 2B) . In a tubulovillous adenoma, the expression of both genes was seen in the villous but not the tubular portions ( Figures 3A and 3B ). In the transitional mucosa immediately adjacent to cancer, expression of both genes was variable, stronger than that of the cancer and equal to or less than that of normal mucosa but occcasionally absent entirely.
Inflammatory Bowel Diseuse
In Crohn's disease, the pattern of MUC2 and MUC3 expression resembled that of normal colon mucosa, regardless of whether the tissue manifested active or quiescent inflammation. As shown in Figure 4 , MUC2 mRNA expression appeared in a typical punctate, goblet cell pattern throughout the colonic crypt in both actively inflamed and uninflamed mucosa. MUC3 mRNA was expressed by goblet and columnar cells of the surface epithelium in much the same pattern as that of normal mucosa, independent of the degree of inflammation. With respect to inter-and intraspecimen variation, specimens derived from different patients demonstrated slight differences in the intensity of MUC2 or MUC3 mRNA expression, but the normal pattern was always present and did not appear to be altered by the degree of inflammation. Within an individual specimen, the pattern of MUCZ and MUC3 mRNA expression was typically found throughout the tissue.
In ulcerative colitis, likewise, MUCZ and MUC3 mRNAs were expressed in a normal pattern despite the presence of active or quiescent inflammation (Figure 5) . In several cases of ulcerative colitis. it appeared that MUC3 mRNA expression not only was restricted to the very surface epithelium but also extended further downward into the upper crypts themselves. As with Crohn's disease, specimens of ulcerative colitis demonstrated minor variations in staining intensity for MUC2 and MUC3 mRNA among different patients, but the normal pattern prevailed without any apparent relationship to the degree of inflammation.
Discussion
The ability to analyze the expression of specific mucin genes has been made possible in recent years by the discovery of several mu-4 Figure 4. Crohn's colitis with active (A,B) and quiescent (C,D) . . cin cDNAs. MUCZ and MUC3 cDNAs were the first to be cloned from an intestinal cDNA library and have frequently been considered the major mucins expressed by intestinal epithelial cells. With respect to normal human intestinal mucosa, our previous studies using Northem blot hybridization indicated that MUCZ and MUC3 mRNAs were well expressed in normal colon mucosa (Ogata et al., 1992) . Using anti-apomucin antibodies, MUCZ apomucin has been detected in goblet cells of human small intestine and colon, whereas MUC3 apomucin was expressed by both goblet cells and columnar cells (Chang et al.. 1994; Lesuffleur et al.. 1994; Ho et al., 1993) . The results of the present study confirm this normal distribution by using in situ hybridization to detect mRNA expression. Other investigators have noted a similar distribution of MUC2 and MUC3 mRNA expression by in situ hybridization in normal human small intestine and colon (Chang et al., 1994; Audie et al., 1993) . These findings suggest that MUCZ is a marker of goblet cell lineage, but its expression throughout the colonic crypt or small intestinal crypt-villous axis indicates that it is not related to the stages of cellular maturation. In contrast. MUC3 appears to be specifically expressed by the most mature cells in the small intestinal villus and the surface epithelium of the colon and, unlike MUC2, is not restricted to goblet cells but is also expressed by columnar cells. Therefore, the regulation of these two mucin genes could be quite different. The fact that a maturational effect exists for MUC3 expression is in keeping with prior observations that increased glycoprotein synthesis occurs from the lower colonic crypt to the surface epithelium, as measured by [3H]-glucosamine and [3H]-fucose incorporation (Neutra and Former, 1987) .
The present finding of diminished MUC2 and MUC3 mRNA expression in colon cancer confirms our earlier studies using Northern blot hybridization (Ogata et al.. 1992) . Likewise, Chang et al. (1994) noted a decrease in MUC2 and MUC3 mRNA expression in human colon cancer by in situ hybridization. In contrast, Ho et al. (1993) , using anti-apomucin antibodies, reported that the expression of MUCZ and MUC3 apomucins was often increased in human colon cancer, a discrepancy that could be related to differences in technique or, more likely. to differences in interpretation between the results of immunohistochemistry and in situ hybridization. There is agreement, however, that colloid carcinomas frequently exhibit high expression of both MUC2 and MUC3 in keeping with the highly mucinous nature of these tumors. Our observation of MUCZ mRNA expression in the villous but not the tubular portion of an adenoma suggests that the villous regions of polyps give rise to the mucinous phenotype of colon cancers. Other investigators have compared villous and tubular adenomas for MUG? apomucin expression by immunohistochemistry and have failed to find any significant differences between the two types of adenomas (Blank et al., 1994) . More studies on colorectal polyps are needed to draw more definitive conclusions. Figure 5. Ulcerative colitis with active (A,B) and quiescent (C,D) inflammation  probed for MUC2 (A,C) and MUC3 (B,D) mRNA expression. In the presence of both active and quiescent inflammation, MUC2 mRNA is expressed by goblet cells throughout the crypt. MUC3 mRNA is expressed by both goblet and columnar cells, and although restricted mainly to the surface epithelium, there is some expression extending further down into the upper crypt. Bars = 50 wm.
Mucous depletion has been considered to be a characteristic histopathological feature of ulcerative colitis, distinguishing it even from Crohn's colitis (Morson and Dawson, 1972) . Although the significance and the mechanism underlying this remain to be elucidated, biochemical studies using ion exchange chromatography have revealed a selective depletion of one of six chromatographic fractions (species IV) in both active and quiescent ulcerative colitis, whereas such a depletion was not observed in Crohn's disease (Podolsky and Isselbacher, 1984) . Moreover, the finding that even healthy twins of patients affected with ulcerative colitis can manifest selective depletion of species IV suggests that this alteration might precede the development of ulcerative colitis rather than representing a response to inflammation (Tysk et al., 1991) . Although other investigators have not been able to confirm this selective mucin depletion in ulcerative colitis (Raouf et al., 1991) , the findings raise the possibility that certain mucin genes could be diminished in ulcerative colitis.
The results of the present study represent the first description of MUC2 and MLJC3 gene expression in human inflammatory bowel disease tissues by in situ hybridization. Curiously, regardless of whether there was active or quiescent inflammation or whether the tissue was from ulcerative colitis or Crohn's disease, the pattern of MUCZ and MUC3 mRNA expression was altered very slightly, if at all, from the pattern of normal mucosa. This argues against the selective reduction of these two genes in ulcerative colitis. In fact, Tytgat et al. (1996) recently reported that, as in the normal colon, MUC2 is a predominant mucin expressed in ulcerative colitis, based on biochemical and immunohistochemical studies. Therefore, the morphological appearance of mucous depletion in ulcerative colitis may reflect an increase in secretion of mucin glycoproteins from goblet cell vacuoles in the setting of continued mucin synthesis by goblet cells.
Literature Cited
